Biotricity, Inc. (BTCY) has a consensus analyst rating of Buy, based on 4 analysts covering the stock. Of those, 2 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for BTCY is $4.00, representing a +1,381.9% upside from the current price of $0.26992. Price targets range from a low of $4.00 to a high of $4.00.
